“Effectiveness and safety of palbociclib and ribociclib as treatment for metastatic breast cancer in a Costa Rican Hospital from 2017 to 2022: Palbociclib y ribociclib en cáncer de mama” (2025) Acta Médica Costarricense, 66(4), pp. 1–9. doi:10.51481/amc.v66i4.1434.